The following adjustment was made today on Teva Pharmaceutical Industries Ltd (TEVA). All prices include IB commissions.
Criteria | Value |
Dividend Champions Status | Contender |
Years of Consecutive Dividend Increases | 13 |
Fair Value Estimate | $58.00 |
Target Buy Price | $40.60 |
Target Margin of Safety | 30.00% |
Actual Buy Price | $40.00 |
Actual Margin of Safety | 31.03% |
Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
6/25/2012 | TEVA | Continued Trade | STO 1 Jul12 42.50 Call @ 0.19 |   |   | $19.27 |
Current Position Summary
Cost Basis | ($4,000.00) |
Income Generated | $70.24 |
Percent Income Generated | 1.76% |
Annualized Income Generated | 5.34% |
Net Profit If Assigned | $320.24 |
Percent Return If Assigned | 8.01% |
Annualized Return If Assigned | 24.35% |
Days Held to Expiration | 120 days |
Trade History
Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
3/22/2012 | TEVA | CSP Margin Used | CSP 100 TEVA @ 40.00 |   | ($4,000.00) |   |
3/22/2012 | TEVA | Initial Put Option | STO 1 May12 40.00 Put @ 0.51 | Exercised |   | $50.97 |
5/18/2012 | TEVA | CSP Margin Returned | CSP 100 TEVA @ -40.00 |   | $4,000.00 |   |
5/18/2012 | TEVA | Stock Assigned | EX 1 May12 40.00 Put @ -40.00 |   | ($4,000.00) |   |
6/25/2012 | TEVA | Continued Trade | STO 1 Jul12 42.50 Call @ 0.19 |   |   | $19.27 |
7/20/2012 | TEVA |   | Totals |   | ($4,000.00) | $70.24 |
DTE | 120 |   | Percent Income/Annualized |   | 1.76% | 5.34% |